Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. - Test2 - elhamkhani - TriplyDB

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

http://www.wikidata.org/entity/Q33642021

about

The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease Recent advances in central cardiovascular control: sex, ROS, gas and inflammation Dendritic Cells and Their Role in Cardiovascular Diseases: A View on Human Studies Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury Inflammation, immunity, and hypertensive end-organ damage Inflammation and hypertension: new understandings and potential therapeutic targets Targeting NADPH oxidases in vascular pharmacology Hypertension: what's sex got to do with it?An update on immune system activation in the pathogenesis of hypertension Darkness at the end of the tunnel: poststenotic kidney injury Immune activation caused by vascular oxidation promotes fibrosis and hypertension Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis The inextricable role of the kidney in hypertension Novel adaptive and innate immunity targets in hypertension.Do high-salt microenvironments drive hypertensive inflammation?Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations.Tumor necrosis factor-α produced in the kidney contributes to angiotensin II-dependent hypertension.Role of the immune system in hypertension: modulation by dietary antioxidants.Interleukin 17 in vascular inflammation.Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.Upregulation of OLR1 and IL17A genes and their association with blood glucose and lipid levels in femoropopliteal artery disease Dual opposing roles of adaptive immunity in hypertension.Cutaneous control of blood pressure.Role of vascular oxidative stress in obesity and metabolic syndrome.Aldosterone and inflammation.A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage Interactions of hyperhomocysteinemia and T cell immunity in causation of hypertension The immune system in hypertension Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.Sex-specific T-cell regulation of angiotensin II-dependent hypertension.Female spontaneously hypertensive rats have a compensatory increase in renal regulatory T cells in response to elevations in blood pressure.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system Interleukin-2/Anti-Interleukin-2 Immune Complex Expands Regulatory T Cells and Reduces Angiotensin II-Induced Aortic Stiffening.The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients Is hypertension an autoimmune disease?Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.Angiotensin II-induced endothelial dysfunction is temporally linked with increases in interleukin-6 and vascular macrophage accumulation.DC isoketal-modified proteins activate T cells and promote hypertension.Inflammation, immunity, and hypertension.Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.

P2860

Q26745592-B4411A8B-F240-4151-8C18-B1B662DE55C7 Q26752442-615FAAFF-19B4-42A2-AD8F-D9193D432496 Q26752811-8D831C02-F163-4737-9792-4B1C662948EB Q26822514-F960CD42-F965-4D42-8738-C2D8CD7911AB Q26827525-25FD2301-0842-4D26-BE43-EB5887055D95 Q26827586-DA36387C-E014-410A-9F17-9FA07B7F3870 Q26863500-3EBCEC60-1114-43DF-9E8B-498A5CABD394 Q26866656-78119910-F108-40E7-B4EE-52C8C074276C Q27013715-EF9167A4-B334-442B-A0A7-7C6F6EE8C993 Q27014398-B793B260-7755-40A3-8394-E440AF8F2C7B Q27332212-74ABD0F2-D04C-438E-A8C2-9EFC6188F7F8 Q28084366-A4B77D51-3E07-4E8E-88D5-252111C88D7A Q28241252-FC8B0E86-D8D0-432F-A97D-ACFBA193F1D7 Q30235116-F0C6617E-7EC5-49F9-AC1F-EE2062D4B069 Q30240293-B6B6B504-8592-4790-B0ED-9A2163D849EA Q30252415-7FC2511C-4924-4771-8448-9EC6DBC66530 Q30365965-62746BEE-BA04-4242-BF76-A839E417121C Q30424339-2BE089F6-22F2-495F-B08B-B382155D31F8 Q30429445-34991D73-70BF-419D-A697-427613DFABE6 Q30589228-C3514D6E-3045-4043-BF36-A29CF9B273DA Q33598191-A10898B4-5B1D-4CCC-9B4C-C4EEE6F17D4B Q33606181-22AB1C5B-AEFA-4CB5-891B-FF1D678780E0 Q33690138-532FB709-9EAA-4764-9AF7-82156C6A9F84 Q33789308-B92CCB71-A1B7-4985-A609-2D79F5526A1A Q33837784-F7028939-E03A-4395-9A81-A9E30B58F758 Q33877762-F74F1E9D-9FA3-4810-922E-72B85406875F Q33920630-116F1555-295D-4C4D-BB27-C84E6CFFC942 Q33957722-E86A1218-958F-4592-B98C-110E09BE9DCB Q34013918-0A71C762-0FA5-4C95-ADF2-DD15C0DBEF89 Q34047021-A03FBD3C-4DCA-4744-90C6-520E2D29A94D Q34051321-A5AECB4C-1FDD-45C4-9C2D-FFC9E022891E Q34062829-8E58716C-3251-4B95-A3FC-C721BC21F0BC Q34203364-56BCC109-265C-4CD5-8761-CE4B2A09F411 Q34309016-BE304412-64D4-4CA5-91A7-2CDC0066626C Q34311505-8F5A0E59-6752-42FC-B973-B7B9B012AFC7 Q34381424-D5075288-9B28-4E2C-AB98-07353DE337C0 Q34419313-E0138E7D-9CF8-4CAF-87F6-61E32EED698E Q34454645-9A5EE4EC-6E89-4D0A-9288-673B361911B1 Q34528283-68CD7789-2ECF-4F61-A661-DD057F29D79E Q34612453-AA3E9E76-B692-4CBB-81FD-67FA0CC49B49

P2860

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

http://www.wikidata.org/entity/Q33642021

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@ast

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@en

type

label

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@ast

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@en

prefLabel

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@ast

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@en

P1433

Q33642021-33B84BF7-55BA-4383-8369-465B47BECF7E

P1476

Q33642021-2BC33E82-3D54-4D47-80A5-19B3BEC7F510

P2093

Q33642021-0651ED47-5646-48C5-A4F6-F5EDFE8F62F8

Q33642021-083F14DA-A1CF-450B-BED7-65746A6CAD10

Q33642021-81ACCD79-675F-4DA0-B179-01DD949A17A9

Q33642021-AE23A9B8-8525-4902-B4EB-94DBEB2D5879

Q33642021-C9C3ABDB-62FE-4BC6-8097-CC2F4E12960D

P2860

Q33642021-03508777-CB06-4D5D-A157-74958FE83C13

Q33642021-0AE9583E-975D-45BB-8D73-0487C067B73E

Q33642021-130A4B09-72E3-4B17-AD34-0B1848AF3948

Q33642021-1CA7ADD0-547E-46A4-AABC-00872798BBB3

Q33642021-409D9D95-9F7C-42B6-80C7-E4FF35E7D2A3

Q33642021-45179DDE-7079-438A-8CC7-0C4BAB119388

Q33642021-45FD47A2-82FD-4F9F-9415-AD6E2015344C

Q33642021-4761B7A2-6E3B-4AC7-B522-C46019F38A24

Q33642021-4E12DC1F-C044-4E82-B44D-49EC8B5980C5

Q33642021-57C16E01-F033-4A8B-A1B2-BE5FFD85B2BB

P304

Q33642021-DA3A7D85-C0CE-4927-9F78-0A0BB5DF28AF

P31

Q33642021-7129CFF2-7D34-491F-A591-ECB4E813D1C8

P356

Q33642021-83376D91-6E55-4647-8BF3-33A061B27A58

P407

Q33642021-9056ED75-0565-4334-B382-A966754D781A

P433

Q33642021-F46ADFE4-B665-42B9-90A0-A1E145CEDB7C

P478

Q33642021-A60F6158-5C52-49FB-B8B5-3F1D2046A1C0

P50

Q33642021-8B14508F-807A-4258-A1BA-E532AD8287DE

Q33642021-EE0C3691-ED2C-443C-84FE-2CCEF6931688

P577

Q33642021-4B57A0D6-4D78-4154-8590-893D6EF2C17D

P698

Q33642021-E170A581-958A-4002-A190-9B74AAA9BF8B

P921

Q33642021-c816d808-25cd-49c3-ab68-5f796330d5a9

P932

Q33642021-49FE2527-0A8F-4DFD-8F1B-6BA144A32425

P356

HYPERTENSIONAHA.109.145094

P1433

P1476

Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

@en

P2093

David G Harrison

http://www.w3.org/2001/XMLSchema#string

Heinrich E Lob

http://www.w3.org/2001/XMLSchema#string

Louise A McCann

http://www.w3.org/2001/XMLSchema#string

Tomasz J Guzik

http://www.w3.org/2001/XMLSchema#string

Yelena Blinder

http://www.w3.org/2001/XMLSchema#string

P2860

Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Functional diversity of helper T lymphocytes

IL-17 induces monocyte migration in rheumatoid arthritis

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Th17 cells in human disease.

Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.

P304

500-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.145094

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Yoichiro Iwakura

P577

2009-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20038749

http://www.w3.org/2001/XMLSchema#string

P921

P932

2819301

http://www.w3.org/2001/XMLSchema#string